(+34) 91 184 19 18 info@qilu-pharma.es

Information about our medicines for neuroscience

The World Health Organization (WHO) defines mental illness as a group of clinically recognizable symptoms and behaviors associated in most cases with discomfort and interference with the ability to function. There are various psychiatric disorders, and different levels of severity. Depression, schizophrenia, bipolar disorder or obsessive-compulsive personality disorders … are different diseases which have in common that they negatively affect, to a greater or lesser extent, the lives of people who suffer them and those of their families.

Depression has a prevalence of 4.4%. According to the WHO, by 2020 depression will be the leading cause of absenteeism in developed countries and the second most common illness worldwide.

Our commitment is to help to improve the health of patients with mental illnesses, as well as to provide professionals with the necessary options for the best treatment.

Our company works to provide solutions that help to improve the quality of life of these patients.

Please contact us for more information about products Qilu Pharmaceutical.